0001612502-16-000001.txt : 20160503 0001612502-16-000001.hdr.sgml : 20160503 20160503112436 ACCESSION NUMBER: 0001612502-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160503 DATE AS OF CHANGE: 20160503 EFFECTIVENESS DATE: 20160503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Symbiomix Therapeutics, LLC CENTRAL INDEX KEY: 0001612502 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-262464 FILM NUMBER: 161614272 BUSINESS ADDRESS: STREET 1: 105 LOCK STREET SUITE 409 CITY: NEWARK STATE: NJ ZIP: 07103 BUSINESS PHONE: 609-722-7250 MAIL ADDRESS: STREET 1: 105 LOCK STREET SUITE 409 CITY: NEWARK STATE: NJ ZIP: 07103 D 1 primary_doc.xml X0707 D LIVE 0001612502 Symbiomix Therapeutics, LLC 105 LOCK STREET SUITE 409 NEWARK NJ NEW JERSEY 07103 609-722-7250 DELAWARE None None Limited Liability Company true 2012 Robert Jacks 105 Lock Street Suite 409 Newark NJ NEW JERSEY 07103 Executive Officer Klaus Veitinger 105 Lock Street Suite 409 Newark NJ NEW JERSEY 07103 Director Rishi Gupta 105 Lock Street Suite 409 Newark NJ NEW JERSEY 07103 Director Thomas Beck 105 Lock Street Suite 409 Newark NJ NEW JERSEY 07103 Director Ben Auspitz 105 Lock Street Suite 409 Newark NJ NEW JERSEY 07103 Director Karen Dawes 105 Lock Street Suite 409 Newark NJ NEW JERSEY 07103 Director Joseph Amprey 105 Lock Street Suite 409 Newark NJ NEW JERSEY 07103 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2016-04-22 false true false 0 6000000 6000000 0 false 4 0 0 0 false Symbiomix Therapeutics, LLC /s/ Robert Jacks Robert Jacks Chief Financial Officer and Secretary 2016-05-03